Abstract:Despite mediating several essential processes in the brain, including during development, cyclin-dependent kinase-like 5 (CDKL5) remains a poorly characterized human protein kinase. Accordingly, its substrates, functions, and regulatory mechanisms have not been fully described. We realized that availability of a potent and selective small molecule probe targeting CDKL5 could enable illumination of its roles in normal development as well as in diseases where it has become aberrant due to mutation. We prepared a… Show more
“…Suppressing CDKL5 expression using a small molecule probe enhances the survival of human motor neurons under endoplasmic reticulum stress conditions. 54 Another outlier gene we identified, HIF1A , contributes to motor neuron degeneration through hypoxic stress, and prolonged survival observed in ALS mice suggests up-regulation of HIF1A as a potential therapeutic target. 55 Finally, VPS4B is pathologically increased in familial and sporadic ALS neuronal nuclei.…”
Section: Resultsmentioning
confidence: 90%
“…We manually curated a list of ALS genes from the literature 1 , 11 , 46 , 47 , 48 , 49 , 50 , 51 , 53 , 54 , 55 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 and ALSOD. 45 The curated list is available at 10.5281/zenodo.8331545.…”
“…Suppressing CDKL5 expression using a small molecule probe enhances the survival of human motor neurons under endoplasmic reticulum stress conditions. 54 Another outlier gene we identified, HIF1A , contributes to motor neuron degeneration through hypoxic stress, and prolonged survival observed in ALS mice suggests up-regulation of HIF1A as a potential therapeutic target. 55 Finally, VPS4B is pathologically increased in familial and sporadic ALS neuronal nuclei.…”
Section: Resultsmentioning
confidence: 90%
“…We manually curated a list of ALS genes from the literature 1 , 11 , 46 , 47 , 48 , 49 , 50 , 51 , 53 , 54 , 55 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 and ALSOD. 45 The curated list is available at 10.5281/zenodo.8331545.…”
“… B1 was simultaneously assayed with other CDKL5 antagonists ( Ong et al, 2023 ). ( A ) Representative graph from a CDKL5 kinase assay demonstrating that purified WT human CDKL5 retains kinase activity, while the kinase dead (KD, CDKL5 K42R) human protein is functionally inactive (n = 3).…”
Section: Resultsmentioning
confidence: 99%
“…***p<0.0001 and nonsignificant comparisons not shown. Control, DMSO, positive (AST-487), and negative (Lapatinib) controls are as in Ong et al, 2023 .…”
Pathological loss-of-function mutations in cyclin-dependent kinase-like 5 (CDKL5) cause CDKL5 deficiency disorder (CDD), a rare and severe neurodevelopmental disorder associated with severe and medically refractory early-life epilepsy, motor, cognitive, visual and autonomic disturbances in the absence of any structural brain pathology. Analysis of genetic variants in CDD have indicated that CDKL5 kinase function is central to disease pathology. CDKL5 encodes a serine-threonine kinase with significant homology to GSK3b, which has also been linked to synaptic function. Further, Cdkl5 knock-out rodents have increased GSK3b activity and often increased long-term potentiation (LTP). Thus, development of a specific CDKL5 inhibitor must be careful to exclude cross-talk with GSK3b activity. We synthesized and characterized specific, high-affinity inhibitors of CDKL5 that do not have detectable activity for GSK3b. These compounds are very soluble in water but blood-brain barrier penetration is low. In rat hippocampal brain slices, acute inhibition of CDKL5 selectively reduces post-synaptic function of AMPA-type glutamate receptors in a dose-dependent manner. Acute inhibition of CDKL5 reduces hippocampal LTP. These studies provide new tools and insights into the role of CDKL5 as a newly appreciated, key kinase necessary for synaptic plasticity. Comparisons to rodent knock-out studies suggest that compensatory changes have limited the understanding of the roles of CDKL5 in synaptic physiology, plasticity and human neuropathology.
“…Similarly, the CDKL5 gene exhibits over-expression with an over-accessible promoter region (protein levels are unavailable). Suppressing CDKL5 expression using a small molecule probe enhances the survival of human motor neurons under endoplasmic reticulum stress conditions 50 . Another outlier gene we identified, HIF1A , contributes to motor neuron degeneration through hypoxic stress, and prolonged survival observed in ALS mice suggests up-regulation of HIF1A as a potential therapeutic target 51 .…”
The high heritability of ALS and similar rare diseases contrasts with their low molecular diagnosis rate post-genetic testing, pointing to potential undiscovered genetic factors. DNA accessibility assays quantify the activity of functional elements genome-wide, offering invaluable insights into dysregulated regions. In this research, we introduced EpiOut, a computational toolbox to identify outliers in DNA accessibility. These outliers represent dysregulated regions where DNA accessibility uniquely diverges from the population baseline in a single or few samples. Annotation of accessible regions with histone ChIP-seq and Hi-C indicates that outliers are concentrated in functional loci, especially among promoters interacting with active enhancers. Across different omics levels, outliers are robustly replicated, and DNA accessibility outliers are reliable predictors of gene expression outliers and aberrant protein levels. For example, 59% of gene expression outliers can be linked to epigenetic changes. A comparison of promoter activity against gene expression reveals if aberration in the molecule phenotype is linked to pre-transcriptional or post-transcriptional regulation. Our findings demonstrate that the outlier detection paradigm can uncover dysregulated regions in rare diseases. EpiOut is open-sourced and freely available at (github.com/uci-cbcl/EpiOut.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.